{'_data': [['Unknown',
            [['GI',
              u'digestive disturbances. Rare: Altered taste, constipation. Very rare: Ileus, intestinal angioedema. Hepato-biliary disorders: Rare: Pancreatitis, hepatic function disturbances. Skin and subcutaneous tissue disorders: Common: Exanthema Uncommon: Pruritus, urticaria, pemphigus, exfoliative dermatitis, diaphoresis, alopecia, photosensitivity Very rare: Erythema multiforme, psoriasis, onycholysis In case of severe skin reactions therapy must be stopped immediately and supervision by a physician is mandatory. Musculoskeletal, connective tissue and bone disorders: Rare: Myalgia, arthralgia. Renal and urinary disorders: Rare: Impaired renal function, hyperkalaemia. General disorders: Common: Headache, tiredness, chest pain. Uncommon: Asthenia. Rare: Angioedema (with swelling of face, lips, tongue, pharynx). The incidence of angioneurotic oedema is increased in black patients. Rare cases of agranulocytosis have been reported, and also a syndrome including fever, serositis, vasculitis, myalgia, arthralgia/arthritis, positive ANA-titre, ESR-elevation, eosinophilia, and leukocytosis. Gynaecomastia and vasculitis have been reported with other ACE-inhibitors and it cannot be excluded that these unwanted effects are group specific. Laboratory values: Transient increases in serum creatinine and urea values have been reported, especially in association with concomitant therapy with diuretics. Slight decreases in haemoglobin and haematocrit values have been reported for other ACE-inhibitors. It cannot be excluded that these observations are group specific.']]]],
 '_pages': [9, 11],
 u'_rank': 1,
 u'_type': u'LSFU'}